Articles From: Response Genetics, Inc. Announces Third Quarter 2014 Financial Results to Retail Opportunity Investments Corp. Schedules Fourth Quarter & Year-End Earnings Release and Conference Call


LOS ANGELES, Nov.
Sign-up for Response Genetics, Inc. Announces Third Quarter 2014 Financial Results investment picks
LONG BEACH, Calif., Dec.
Sign-up for Response to Bloomberg Article About UTi Worldwide and DSV A/S investment picks
2011/04/06
Columnist John F.
Sign-up for Response to Structured Products Letter to the Editor investment picks
The Motorola Solutions Foundation , the philanthropic arm of Motorola Solutions, Inc. (NYSE: MSI), today announced a grant to RESOLVE to help expand the Solutions for Hope platform in the Democratic Republic of the Congo (DRC), Colombia and other countries.
Sign-up for Responsible Sourcing “Solutions for Hope” Program to Expand in the Congo, Colombia and Beyond with Motorola Solutions Foundation Grant investment picks
2014/10/28
ADVISORY, Oct.
Sign-up for Restamax Oyj to Ring The Nasdaq Stock Market Closing Bell investment picks
Restaurant Brands International Announces Successful Completion of Tim Hortons and Burger King Transaction Canada NewsWire OAKVILLE, ON , Dec.
Sign-up for Restaurant Brands International Announces Successful Completion of Tim Hortons and Burger King Transaction investment picks
2014/12/12
Restaurant Brands International Inc. (TSX, NYSE: QSR) is pleased to announce the successful completion of the transaction with Tim Hortons Inc. (TSX, NYSE: THI) and Burger King Worldwide, Inc. (NYSE: BKW). The transaction creates Restaurant Brands International, a new global quick service restaurant leader operating two iconic, independent brands.
Sign-up for Restaurant Brands International Announces Successful Completion of Tim Hortons and Burger King Transaction investment picks
2014/12/1
Restoration Hardware Holdings, Inc. (NYSE:RH) today announced the amendment and expansion of the Company’s existing senior secured revolving credit facility to $600 million with a maturity in November 2019.
Sign-up for Restoration Hardware Announces Expanded $600 Million Senior Secured Revolving Credit Facility investment picks
2014/12/1
RH (Restoration Hardware Holdings, Inc.—NYSE: RH) announced today the opening, on November 21, of RH Atlanta, The Gallery at the Estate in Buckhead at 3030 Peachtree Road NW.
Sign-up for Restoration Hardware Announces the Opening of RH Atlanta, the Gallery at the Estate in Buckhead investment picks
2014/10/24
RH (Restoration Hardware Holdings, Inc.—NYSE: RH) announced today the opening of RH West Hollywood, The Gallery on Melrose Avenue at 8564 Melrose Avenue, in the heart of the Los Angeles Design District.
Sign-up for Restoration Hardware Announces the Opening of RH West Hollywood, The Gallery on Melrose Avenue investment picks
2014/12/10
Restoration Hardware Holdings Inc. (RH) shares rose in the extended session Wednesday after the high-end home furnishings retailer's quarterly results topped Wall Street expectations.
Sign-up for Restoration Hardware shares rise after earnings beat investment picks
2014/12/4
Results for the third quarter ended October 31, 2014 Canada NewsWire TERREBONNE, QC , Dec.
Sign-up for Results for the third quarter ended October 31, 2014 investment picks
No evidence of negative effects on bone mineral density Treatment benefit is sustained with 79.3% of subjects exhibiting normal morning testosterone after 12 months of treatment (LOCF 71.4%) No new safety signals detected with long-term treatment THE WOODLANDS, Texas, Oct.
Sign-up for Results From Long-Term Study of Androxal(R) Exhibit Positive Safety Profile investment picks
La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that detailed results from its Phase 2 study of GCS-100 in chronic kidney disease (CKD) patients are being presented at a poster session ( Glomerular and Tubulointerstitial Disease: Clinical Trials and Outcomes , November 13, 10:00 a.m. - 12:00 p.m. Eastern Standard Time, Poster TH-PO460 ) at the American Society of Nephrology’s (ASN) Kidney Week Annual Meeting.
Sign-up for Results from Phase 2 Study of GCS-100 in Chronic Kidney Disease Being Presented at American Society of Nephrology Kidney Week investment picks
Celgene Corporation (NASDAQ:CELG) today announced results from an international phase III study of REVLIMID® (lenalidomide) compared with placebo in patients with red-blood cell (RBC) transfusion dependent low-risk myelodysplastic syndromes (MDS) who were unresponsive or refractory to erythropoietin stimulating agents (ESA) and did not have a deletion 5q cytogenic abnormality.
Sign-up for Results from Phase III Study of REVLIMID® (Lenalidomide) Demonstrating Improved Transfusion Independence in Patients with Rare Blood Cancer, Non-Del-5Q Myelodysplastic Syndromes (MDS), Presented at ASH investment picks
These Studies and Genomic Health's First Liquid Biopsy Study in Bladder Cancer To Be Presented at 2014 Society of Urologic Oncology Annual Meeting, December 3-5 Authors: Isabell Sesterhenn , Timothy Brand , Inger Rosner , Joel Moncur , Amina Ali , Yongmei Chen , Nan Zhang , Athanasios Tsiatis , Dejan Knezevic , Tara Maddala , H.
Sign-up for Results from Second Oncotype DX® Prostate Cancer Test Clinical Validation and First Decision Impact Study To Be Published in European Urology and Urology Practice, Respectively investment picks
Genzyme , a Sanofi company, announced today that the Food and Drug Administration (FDA) has approved the inclusion of efficacy and safety data from the TOWER and TOPIC studies of once-daily, oral Aubagio ® (teriflunomide) in the product’s U.S. label.
Sign-up for Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio investment picks
TSX Exchange Symbol: RVX CALGARY , Oct.
Sign-up for Resverlogix Corporate Update Conference Call & Webcast Announcement investment picks
Resverlogix Names Michael Sweeney, M.D., as Senior Vice President of Clinical Development Canada NewsWire CALGARY , Nov.
Sign-up for Resverlogix Names Michael Sweeney, M.D., as Senior Vice President of Clinical Development investment picks
Cowen Group, Inc. (“Cowen”) (NASDAQ:COWN) today announced that Oliver Chen has joined Cowen and Company’s Equity Research department as a Managing Director to cover specialty retail, broadlines & department stores, and luxury stocks.
Sign-up for Retail Analyst Oliver Chen Joins Cowen’s Equity Research Department investment picks
2014/11/25
(FROM THE WALL STREET JOURNAL 11/26/14) By Matina Stevis and Ian Walker Furniture retailer Steinhoff International Holdings Ltd.
Sign-up for Retail Deal Spans Europe And Africa investment picks
SAN DIEGO, Oct.
Sign-up for Retail Opportunity Investments Corp. Reports Solid Third Quarter Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Response Genetics, Inc. Announces Third Quarter 2014 Financial Results to Retail Opportunity Investments Corp. Schedules Fourth Quarter & Year-End Earnings Release and Conference Call
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent